Loading

Creative Structures for Keeping Innovation Alive After the Deal

June 03, 2024
Breakout Session
Business Development and Investment
29AB
Life sciences transactions often focus on innovation and keeping that innovation alive is critical to ongoing success. In this panel, panelists will explore several different M&A and licensing models for keeping the innovation engine going including: acquired companies operating independently; option deals that maintain autonomy up to a certain development phase; milestone payments and contingent value rights; and employee retention plans. The session will engage our esteemed panelists from the pharma and biotech sectors, on their and their companies’ experiences and lessons learned, including a discussion on the M&A and licensing tactics that have been most successful.
Speakers
Oren Livne, JD, MBA
Partner
Baker McKenzie
Speakers
Casarine Chong
Senior Vice President, Deputy General Counsel, Transactions
Bristol Myers Squibb
Gavin Liu, JD
Senior Director, Legal Strategic Transactions
Astellas
Ellen Lubman, MBA
Chief Business Officer
Werewolf Therapeutics
Maria Nichol
Chief Business Officer
Artax Biopharma
Deepa Talpade
Vice President, Head BD&L and Alliance Mgmt., Oncology
Bayer
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS